-
STRUCTURAL BARRIERS TO PATIENT ACCESS FOR INNOVATIVE PET/SPECT RADIOTRACERS: A COMPARATIVE ANALYSIS ACROSS NINE EUROPEAN MARKETS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF NEWBORN SCREENING FOR SPINAL MUSCULAR ATROPHY IN CHINA
Aug 11, 2026, 17:16 PM -
METHODOLOGICAL CONSIDERATIONS AND RECOMMENDATIONS FOR GENERATING AND INTERPRETING QUALITATIVE PATIENT EXPERIENCE DATA ON MEANINGFUL CHANGE IN RARE PAEDIATRIC CONDITIONS
Aug 11, 2026, 17:16 PM -
DECENTRALIZED HEALTH ECONOMICS IN PRACTICE: EVIDENCE FROM STUDIES CONDUCTED BY HEALTH ECONOMICS UNITS IN BRAZIL'S UNIFIED HEALTH SYSTEM
Aug 11, 2026, 17:16 PM -
CROSS-MARKET HTA OUTCOMES FOR GENE THERAPIES AND CAR-T CELL THERAPIES IN EU4 & UK MARKETS: A HISTORICAL REVIEW OF ACCESS PREFERENCES
Aug 11, 2026, 17:16 PM -
IMPACT OF REIMBURSEMENT POLICY CHANGES ON SGLT2 INHIBITORS UTILIZATION AND NATIONAL HEALTH FUND (NFZ) EXPENDITURE IN POLAND, 2019-2024
Aug 11, 2026, 17:16 PM -
BALANCING EFFICACY AND RESOURCE USE: A PRAGMATIC APPROACH TO PRURITUS MANAGEMENT IN DIALYSIS PATIENTS IN US DIALYSIS ORGANIZATION
Aug 11, 2026, 17:16 PM -
A DECADE OF ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT IN PORTUGAL: TRENDS IN CLINICAL EVALUATION AND FUNDING RECOMMENDATIONS (2016-2025)
Aug 11, 2026, 17:16 PM -
LONG-TERM FINANCIAL SUSTAINABILITY OF THE COMPULSORY HEALTH INSURANCE SYSTEM
Aug 11, 2026, 17:16 PM -
USING TOKENIZATION TO OVERCOME LIMITATIONS OF CLAIMS DATA TO IDENTIFY USE OF REMOTE PATIENT MONITORING AMONG PATIENTS WITH PERITONEAL DIALYSIS
Aug 11, 2026, 17:16 PM -
REAL-WORLD EPIDEMIOLOGY, TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF MYOCARDIAL INFARCTION IN DUBAI
Aug 11, 2026, 17:16 PM -
ORGANIZATIONAL IMPACTS IN HEALTH TECHNOLOGY ASSESSMENT: A DECISION FRAMEWORK FOR EVIDENCE GENERATION
Aug 11, 2026, 17:16 PM -
DISPARITIES AND UNMET NEEDS IN VAGINITIS PATIENTS JOURNEY IN EUROPE AND THE UNITED STATES
Aug 11, 2026, 17:16 PM -
COST IMPACT OF TAFASITAMAB COMBINED WITH LENALIDOMIDE AND RITUXIMAB IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A TIME TO NEXT TREATMENT AND NUMBER NEEDED TO TREAT BASED PHARMACOECONOMIC ANALYSIS
Aug 11, 2026, 17:16 PM -
COMPARATIVE STUDY OF TTO-BASED, HYBRID, AND DCE WITH DURATION VALUE SETS FOR EQ-5D-5L IN QATAR
Aug 11, 2026, 17:16 PM -
DECENTRALIZATION OF HIGHLY COMPLEX TREATMENTS IN LATIN AMERICA: A SYSTEMATIC REVIEW OF CLINICAL, OPERATIONAL, AND ECONOMIC OUTCOMES
Aug 11, 2026, 17:16 PM -
INCREMENTAL TIGHTENING OF JAPAN'S DRUG PRICING SYSTEM: IMPLICATIONS OF THE FY2026 REFORM
Aug 11, 2026, 17:16 PM -
REAL-WORLD EFFECTIVENESS AND COST-EFFECTIVENESS OF PERTUZUMAB PLUS TRASTUZUMAB FOR HER2-POSITIVE ADVANCED BREAST CANCER IN CHINA
Aug 11, 2026, 17:16 PM -
ESTIMATING THE BENEFITS OF AMBULATORY DELIVERY OF CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR T) THERAPY FOR ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA (B-ALL) IN THE UNITED KINGDOM (UK)
Aug 11, 2026, 17:16 PM -
INTEGRATING ENVIRONMENTAL SUSTAINABILITY INTO HEALTH TECHNOLOGY ASSESSMENT: A SCOPING REVIEW AND COMPARATIVE APPLICATION OF INTEGRATION METHODS USING AN INHALER CASE STUDY
Aug 11, 2026, 17:16 PM
